DOT1L Is a Novel Cancer Stem Cell Target for Triple-Negative Breast CancerDOT1Li Targets TNBC Stem Cells

Overview of attention for article published in Clinical Cancer Research, February 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

blogs: 2 blogs

twitter: 8 X users

Readers on

mendeley: 68 Mendeley

So far, Altmetric has seen 11 X posts from 8 X users, with an upper bound of 36,932 followers.

RT @cancerscnews: #DOT1L is a key cancer stem cell regulator in #TripleNegativeBreastCancer (#TNBC), according to a @CCR_AACR paper from sc…

#DOT1L is a key cancer stem cell regulator in #TripleNegativeBreastCancer (#TNBC), according to a @CCR_AACR paper from scientists at @Georgetown and @UMiamiMedicine. 📃 https://t.co/AiCF5AWIjQ https://t.co/KNyJW8g1oZ

RT @cancerscnews: Dr. Joyce Slingerland and colleagues delineated DOT1L as a key #cancer #StemCell regulator in triple-negative #BreastCanc…

@RobClarkeLab

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 7 additional X posts.